High levels of the protein suPAR in the blood of a person with COVID-19 may be a predictor of a more severe disease course. A new study suggests that the protein soluble urokinase plasminogen activator receptor (suPAR) may help scientists predict who is likely to develop more severe COVID-19.
The research, published as a research letter in the journal Critical Care, may help clinicians identify people who are more likely to need intensive care support.
It may also help them identify those who can safely manage the disease at home. Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.